logo-loader
viewAmphion Innovations PLC

Amphion's partner company WellGen signs licence agreement

The market for such products has been expanding rapidly in recent years and WellGen believes there is a place for a black tea-based beverage whose anti-inflammatory properties have been clinically proven

Man in gym
Who doesn't like a nice swig of tea after a fierce workout?

Companies backer Amphion Innovations PLC (LON:AMP) said its partner company WellGen has signed a licence agreement with Missouri-based drinks companies Sportables and One11 Innovation.

WellGen is set to receive 11% of the profits derived from the commercial development and sale of Workout Tea, a beverage based on a patented and clinically proven anti-inflammatory ingredient derived from a black tea extract.

WATCH Amphion Innovations president on significant partner developments and strategy​

WellGen's proprietary Black Tea Extract is scientifically derived and the clinical trials demonstrated improved performance and recovery benefits such as a reduction in muscle soreness and reduced recovery time after physical exercise.

WorkOut Tea is currently available in select stores in the US in a number of flavours.

Amphion has a 27% stake in Wellgen.

Quick facts: Amphion Innovations PLC

Price: 0.15 GBX

AIM:AMP
Market: AIM
Market Cap: £314.96 k
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Amphion Innovations PLC named herein, including the promotion by the Company of Amphion Innovations PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read